A host of companies are competing to bring cancer-detecting blood tests to market.

The FDA could approve the first blood test that can detect multiple cancers, around the end of the year, setting the stage for it to become widely available.

Forbes contributors publish independent expert analyses and insights. Jesse Pines is an expert in healthcare innovation and wellness. This voice experience is generated by AI. Learn more. This voice ...

If you can’t prevent cancer, the best chances of treating or surviving it may come down to finding a tumor early when it hasn’t yet spread. A new test called Cancerguard offers to screen for more than ...

Some claim the new multi-cancer detection tests will “revolutionize” cancer screening. Others fear the “worried well” will succumb to slick marketing and subpar tests and overwhelm both primary care ...

Cervical cancer screenings are considered one of the most significant public health advances of the past 50 years, particularly in detecting HPV (human papillomavirus), the culprit of most cervical ...

A large analysis suggests that a multivariable risk assessment tool, called Stockholm3, can detect substantially more ...

The number of Britons in their 50s who take part in bowel cancer screening remains critically low, the NHS has warned.